"ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY
- 1 February 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 307 (7954) , 292-296
- https://doi.org/10.1016/s0140-6736(76)91416-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- APPRAISAL OF LONG-TERM LEVODOPA TREATMENT OF PARKINSONISM WITH SPECIAL REFERENCE TO THERAPY LIMITING FACTORSActa Neurologica Scandinavica, 2009
- BROMOCRIPTINE IN PARKINSONISMThe Lancet, 1975
- BROMOCRIPTINE IN PARKINSONISMThe Lancet, 1975
- DYSKINESIAS DURING LEVODOPA THERAPYThe Lancet, 1975
- DIPHASIC DYSKINESIA DURING LEVODOPA THERAPYThe Lancet, 1975
- A YEAR'S COMPARISON OF TREATMENT OF PATIENTS WITH PARKINSON'S DISEASE WITH LEVODOPA COMBINED WITH CARBIDOPA VERSUS TREATMENT WITH LEVODOPA ALONEThe Lancet, 1973
- SUSTAINED LEVODOPA THERAPY IN PARKINSONISMThe Lancet, 1973
- "On-Off" Phenomena Related to High Plasma LevodopaBMJ, 1973
- SERUM-MONOAMINE-OXIDASE LEVELS DURING LEVODOPA THERAPYThe Lancet, 1971
- LONG-TERM SIDE-EFFECTS OF LEVODOPAThe Lancet, 1971